TAO Synergies TAOX
NASDAQ TAOX
$4.14 +0.13 (+3.24%)
As of: Sep 9, 2026 · 11:58 AM EDT

TAO Synergies (TAOX) Net Cash Flow (2019 - 2026)

TAO Synergies' (TAOX) quarterly Net Cash Flow came in at -$1.3 million in Q2 2026, down 131.65% on a YoY basis from $4.0 million in Q2 2025, and up 31.02% quarter-over-quarter from -$1.9 million in Q1 2026.

Analysis

TAO Synergies (TAOX) Net Cash Flow (2019 - 2026) Analysis & Trends

TAO Synergies (TAOX) has reported Net Cash Flow for 8 consecutive years, with -$1.3 million the latest figure, recorded in Q2 2026.

  • For the quarter ending Q2 2026, Net Cash Flow fell 131.65% year-over-year to -$1.3 million; the trailing twelve-month figure through Jun 2026 stood at -$12.0 million (down 571.55% YoY), and the FY2025 full-year result was -$12.2 million, down 10.48% from the prior year.
  • Net Cash Flow improved to -$1.3 million in Q2 2026 per TAOX's latest filing, from -$1.9 million in the prior quarter.
  • Across five years, Net Cash Flow topped out at $11.1 million in Q4 2022 and bottomed at -$12.9 million in Q3 2025.
  • Historically, Net Cash Flow has averaged -$1.2 million across 5 years, with a median of -$1.8 million in 2023.
  • The widest YoY moves for Net Cash Flow: up 398.22% in 2025, down 1153.51% in 2025.
  • Over 5 years, Net Cash Flow stood at $11.1 million in 2022, then slumped by 127.51% to -$3.1 million in 2023, then soared by 35.76% to -$2.0 million in 2024, then jumped by 305.74% to $4.1 million in 2025, then sank by 131.52% to -$1.3 million in 2026.
  • According to Business Quant data, Net Cash Flow over the past three periods registered -$1.3 million, -$1.9 million, and $4.1 million for Q2 2026, Q1 2026, and Q4 2025 respectively.
Peer Set

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr) Net Cash Flow (Qtr)
1 Amgen 211.88 Bn 197.89 Bn 7.24 Bn 1.95 Bn
2 Gilead Sciences 181.55 Bn 178.37 Bn 6.22 Bn -4.43 Bn
3 Vertex Pharmaceuticals 132.31 Bn 124.45 Bn 2.84 Bn 652.90 Mn
4 Regeneron Pharmaceuticals 82.51 Bn 74.52 Bn 3.93 Bn -504.30 Mn
5 Argenx Se 61.54 Bn 56.36 Bn 1.37 Bn -
6 Moderna 54.69 Bn 49.55 Bn 52.00 Mn -183.00 Mn
7 Alnylam Pharmaceuticals 34.07 Bn 30.76 Bn 992.69 Mn -496,000.00
8 Biogen 31.41 Bn 30.12 Bn 1.96 Bn -2.09 Bn
9 Roivant Sciences 30.10 Bn 30.10 Bn 1.16 Mn -170.75 Mn
10 TAO Synergies 30.93 Mn 30.93 Mn - -1.28 Mn
Historic Data

Historic Data

Download Data
DateValue
Jun 30, 2026 -1.28 Mn
Mar 31, 2026 -1.85 Mn
Dec 31, 2025 4.05 Mn
Sep 30, 2025 -12.92 Mn
Jun 30, 2025 4.04 Mn
Mar 31, 2025 -2.82 Mn
Dec 31, 2024 -1.97 Mn
Sep 30, 2024 -1.03 Mn
Jun 30, 2024 -1.35 Mn
Mar 31, 2024 -2.33 Mn
Dec 31, 2023 -3.07 Mn
Sep 30, 2023 -1.17 Mn
Jun 30, 2023 -1.24 Mn
Mar 31, 2023 -1.70 Mn
Dec 31, 2022 11.14 Mn
Sep 30, 2022 -2.42 Mn
Jun 30, 2022 -2.52 Mn
Mar 31, 2022 -2.93 Mn
Dec 31, 2021 2.92 Mn
Sep 30, 2021 -407,441.00